Table 2.
Shock patient comparison (at T0)
| Control group (n = 19) |
CVVH group (n = 21) |
P value | |
| Heart rate | 114 ± 20 | 121 ± 14 | 0.18 |
| MAP (mmHg) | 65 ± 13 | 61 ± 8 | 0.25 |
| CVP (cmH2O) | 18 ± 6 | 19 ± 8 | 0.85 |
| Norepinephrine dose (μg/min) | 4.2 ± 4.3 | 10.0 ± 12.6 | 0.06 |
| Dopamine dose (μg/kg/min) | 1.8 ± 3.6 | 0 | < 0.0001 |
| Vasopressin dose (units/min) | 0.016 ± 0.020 | 0.038 ± 0.009 | < 0.0001 |
| Neosynephrine dose (μg/min) | 4.9 ± 21.3 | 0 | < 0.0001 |
| Dobutamine dose (μg/kg/min) | 0.26 ± 1.1 | 7.6 ± 7.8 | < 0.001 |
| Mean lactate (mmol/L) | 2.9 ± 1.8 | 5.1 ± 4.2 | 0.12 |
| Steroids | 53% | 33% | 0.22 |
All values reported as means ± standard deviation except for steroids.
CVP = central venous pressure; CVVH = continuous venovenous hemofiltration; MAP = mean arterial pressure.